Clinical trial
Combination Drug Treatment of Pediatric HIV Infection
NCT00001818 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001818 |
|---|---|
| Title | Combination Drug Treatment of Pediatric HIV Infection |
| Official title | A Pilot Study of Hydroxyurea in Combination With Stavudine, Didanosine and Efavirenz in Pediatric Patients With HIV-1 Infection |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | Hydroxyurea |
| Enrollment | 50 |
| Start date | Jun 1, 1999 |
| Completion | Nov 1, 2001 |
| First posted | May 22, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: